EP Patent

EP1768649A2 — Pharmaceutical composition of piperazine derivatives

Assigned to UCB Farchim SA · Expires 2007-04-04 · 19y expired

What this patent protects

The present invention relates to a liquid composition containing an active substance belonging to the family of substituted benzhydryl piperazines with reduced amounts of preservatives.

USPTO Abstract

The present invention relates to a liquid composition containing an active substance belonging to the family of substituted benzhydryl piperazines with reduced amounts of preservatives.

Drugs covered by this patent

levocetirizine-dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Patent Metadata

Patent number: EP1768649A2
Jurisdiction: EP
Classification: —
Expires: 2007-04-04
Drug substance claim: No
Drug product claim: No
Assignee: UCB Farchim SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.